{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Century Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"IPSC"},"Address":{"label":"Address","value":"3675 MARKET STREET, PHILADELPHIA, Pennsylvania, 19104, United States"},"Phone":{"label":"Phone","value":"+1 267 817-5790"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a plays a central role in the production of blood cells in the bone marrow. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies."},"CompanyUrl":{"label":"Company Url","value":"https://www.centurytx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adrienne Farid","title":"Chief Operations Officer"},{"name":"Brent Pfeiffenberger","title":"President, Chief Executive Officer & Director"},{"name":"Gregory Russotti","title":"Chief Technology & Manufacturing Officer"},{"name":"Nick Trede","title":"SVP, Head-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}